Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma

Jordi Bruix, Josep M Llovet, Josep Fuster, Prognosis of hepatocellular carcinoma. Hepato-gastroenterology. ,vol. 49, pp. 7- 11 ,(2002)

Kojiro Michitaka, Norio Horiike, Masao Miyagawa, Morikazu Onji, Yoichi Hiasa, Bunzo Matsuura, Yoichi Otomi, Ichiro Sogabe, Tomoyuki Ninomiya, Aki Hasebe, Atsushi Hiraoka, Yoshimasa Yamashita, Yohei Koizumi, Yasunao Miyamoto, Masashi Hirooka, Hideki Kawasaki, Yoshihiro Ishimaru, Kenichi Kashihara, Yasunori Yamamoto, Hirokazu Doi, Makoto Yano, Masahiro Kogame, Kazuto Takamura, Hiromi Ootani, Soichiro Ichikawa, Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization. Hepato-gastroenterology. ,vol. 56, pp. 213- 217 ,(2009)

Josep M Llovet, Jordi Bruix, Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology. ,vol. 37, pp. 429- 442 ,(2003) , 10.1053/JHEP.2003.50047

Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jiejun Wang, Won Young Tak, Hongming Pan, Karin Burock, Jessie Zou, Dimitris Voliotis, Zhongzhen Guan, None, Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncology. ,vol. 10, pp. 25- 34 ,(2009) , 10.1016/S1470-2045(08)70285-7

R. Testa, E. Testa, E. Giannini, F. Botta, F. Malfatti, B. Chiarbonello, A. Fumagalli, S. Polegato, E. Podesta, P. Romagnoli, D. Risso, G. Cittadini, G. DE Caro, Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Alimentary Pharmacology & Therapeutics. ,vol. 17, pp. 1563- 1569 ,(2003) , 10.1046/J.1365-2036.2003.01647.X

Yuko Takeba, Toshio Kumai, Naoki Matsumoto, Sachiko Nakaya, Yoshimitsu Tsuzuki, Yohei Yanagida, Shinichi Kobayashi, Irinotecan Activates p53 With Its Active Metabolite, Resulting in Human Hepatocellular Carcinoma Apoptosis Journal of Pharmacological Sciences. ,vol. 104, pp. 232- 242 ,(2007) , 10.1254/JPHS.FP0070442

Yu Sakata, Yoshiyuki Shimamura, Kenji Jinno, Akira Takahashi, Kenichi Takayasu, Kazuo Tamura, Naofumi Nagasue, Yoshimi Nakanishi, Masaoki Makino, Manabu Masuzawa, Shuichi Mikuriya, Morito Monden, Yasuhiro Yumoto, Takesada Mori, Toshitsugu Oda, , Saburo Kawai, Jun Okamura, Makoto Ogawa, Yasuo Ohashi, Masayoshi Tani, Jushiro Inoue, Yoshifumi Kawarada, Mitsuo Kusano, Yasuhiko Kubo, Chikazumi Kuroda, Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma. A comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study) Cancer Chemotherapy and Pharmacology. ,vol. 31, pp. 1- 6 ,(1992) , 10.1007/BF00687096

Jordi Bruix, Morris Sherman, Josep M Llovet, Michel Beaugrand, Riccardo Lencioni, Andrew K Burroughs, Erik Christensen, Luigi Pagliaro, Massimo Colombo, Juan Rodés, None, Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference Journal of Hepatology. ,vol. 35, pp. 421- 430 ,(2001) , 10.1016/S0168-8278(01)00130-1

Jordi Bruix, Margarita Sala, Josep M. Llovet, Chemoembolization for hepatocellular carcinoma. Gastroenterology. ,vol. 127, pp. 179- 188 ,(2004) , 10.1053/J.GASTRO.2004.09.032

Riccardo Lencioni, Loco-regional treatment of hepatocellular carcinoma. Hepatology. ,vol. 52, pp. 762- 773 ,(2010) , 10.1002/HEP.23725